Technical Analysis for PSNL - Personalis, Inc.
| ADX | Long Term | Intermediate Term | Short Term |
|---|---|---|---|
| Weak or Absent | Up | Down | Down |
| Date | Alert Name | Type | % Chg |
|---|---|---|---|
| 180 Bearish Setup | Bearish Swing Setup | 0.00% | |
| Stochastic Buy Signal | Bullish | 0.00% | |
| Lower Bollinger Band Walk | Weakness | 0.00% | |
| Wide Bands | Range Expansion | 0.00% | |
| Below Lower BB | Weakness | 0.00% | |
| Lower Bollinger Band Touch | Weakness | 0.00% | |
| Oversold Stochastic | Weakness | 0.00% | |
| Lower Bollinger Band Walk | Weakness | -6.23% | |
| Wide Bands | Range Expansion | -6.23% | |
| Gapped Down | Weakness | -6.23% |
| Alert | Time |
|---|---|
| 60 Minute Opening Range Breakdown | about 18 hours ago |
| Fell Below Lower Bollinger Band | about 18 hours ago |
| Possible NR7 | about 18 hours ago |
| Down 5% | about 22 hours ago |
| Down 3% | about 22 hours ago |
Free Daily (Stock) Chart Reading
Let us help you stay on top of your investments. We will alert you to important technical developments on your
portfolio & watchlist.
Configure default chart indicators
Basic chart:
- Earnings date: 11/05/2024
Personalis, Inc. operates as a cancer genomics company worldwide. The company provides sequencing and data analysis services to support the development of cancer therapies. It offers NeXT Platform, which provides data for cancer therapy development, personalized therapies, therapy selection, and diagnostics. The company also provides a complementary liquid biopsy assay that analyzes various human genes versus. It serves approximately 45 biopharmaceutical customers, including a range of pharmaceutical companies. The company was founded in 2011 and is headquartered in Menlo Park, California.
Sector: Healthcare
Industry: Biotechnology
Keywords: Biotechnology Biopharmaceutical Cancer Life Sciences Pharmaceutical Biology Telehealth Telemedicine Genomics Medical Genetics Molecular Diagnostics Applied Genetics Cancer Therapies Analysis Services Biopsy Data Analysis Services Cancer Therapy Oncogenomics Treating Cancer
Classification
Sector: Healthcare
Industry: Biotechnology
Keywords: Biotechnology Biopharmaceutical Cancer Life Sciences Pharmaceutical Biology Telehealth Telemedicine Genomics Medical Genetics Molecular Diagnostics Applied Genetics Cancer Therapies Analysis Services Biopsy Data Analysis Services Cancer Therapy Oncogenomics Treating Cancer
| Indicator | Bull Case | Neutral / Hold | Bear Case |
|---|---|---|---|
| 50 DMA | |||
| 200 DMA | |||
| ADX Trend | |||
| Oversold / Overbought | |||
| Relative Strength |
| Indicator | Value |
|---|---|
| 52 Week High | 7.2 |
| 52 Week Low | 1.12 |
| Average Volume | 760,322 |
| 200-Day Moving Average | 2.90 |
| 50-Day Moving Average | 4.94 |
| 20-Day Moving Average | 4.70 |
| 10-Day Moving Average | 4.27 |
| Average True Range | 0.47 |
| RSI (14) | 34.21 |
| ADX | 17.27 |
| +DI | 20.32 |
| -DI | 30.45 |
| Chandelier Exit (Long, 3 ATRs) | 4.42 |
| Chandelier Exit (Short, 3 ATRs) | 4.74 |
| Upper Bollinger Bands | 5.94 |
| Lower Bollinger Band | 3.45 |
| Percent B (%b) | 0.0 |
| BandWidth | 53.08 |
| MACD Line | -0.33 |
| MACD Signal Line | -0.16 |
| MACD Histogram | -0.1674 |
| Pivot Point Level | Traditional / Classic | Fibonacci | Demark | Woodie | Camarilla |
|---|---|---|---|---|---|
| Resistance 4 (R4) | 4.01 | ||||
| Resistance 3 (R3) | 4.05 | 3.92 | 3.92 | ||
| Resistance 2 (R2) | 3.92 | 3.78 | 3.89 | 3.89 | |
| Resistance 1 (R1) | 3.69 | 3.69 | 3.62 | 3.64 | 3.85 |
| Pivot Point | 3.55 | 3.55 | 3.52 | 3.53 | 3.55 |
| Support 1 (S1) | 3.32 | 3.41 | 3.26 | 3.28 | 3.07 |
| Support 2 (S2) | 3.19 | 3.33 | 3.16 | 3.03 | |
| Support 3 (S3) | 2.96 | 3.19 | 3.00 | ||
| Support 4 (S4) | 2.91 |
